Hide-and-seek: the challenge of viral persistence in HIV-1 infection
- PMID: 17845138
- DOI: 10.1146/annurev.med.59.062806.123001
Hide-and-seek: the challenge of viral persistence in HIV-1 infection
Abstract
The success of highly active antiretroviral therapy (HAART) for HIV-1 infection has sparked interest in mechanisms by which the virus can persist despite effectively suppressive therapy. Latent HIV-1 reservoirs established early during infection not only prevent sterilizing immunity but also represent a major obstacle to virus eradication. When HIV-1 gains a foothold in the immunologic memory or in certain inaccessible compartments of the human body, it cannot be easily purged by HAART and is able to replenish systemic infection on treatment interruption. Because latently infected cells are indistinguishable from uninfected cells, deliberate activation of latent infection combined with intensified HAART seems to be the best strategy to combat latent infection. Initial hypothesis-driven clinical trials did not achieve their ultimate goal, although they provided valuable insight for the design of future eradication protocols. A more detailed understanding of the basic mechanisms underlying the establishment and long-term maintenance of HIV-1 reservoirs will be critical in developing new eradication approaches.
Similar articles
-
Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy.Annu Rev Immunol. 2000;18:665-708. doi: 10.1146/annurev.immunol.18.1.665. Annu Rev Immunol. 2000. PMID: 10837072 Review.
-
Reservoirs of HIV-1 in vivo: implications for antiretroviral therapy.AIDS Rev. 2003 Jan-Mar;5(1):3-18. AIDS Rev. 2003. PMID: 12875103 Review.
-
Latency: the hidden HIV-1 challenge.Retrovirology. 2006 Jan 16;3:7. doi: 10.1186/1742-4690-3-7. Retrovirology. 2006. PMID: 16412247 Free PMC article. Review.
-
Epigenetic regulation of HIV-1 persistence and evolving strategies for virus eradication.Subcell Biochem. 2013;61:479-505. doi: 10.1007/978-94-007-4525-4_21. Subcell Biochem. 2013. PMID: 23150264 Review.
-
HIV-1 regulation of latency in the monocyte-macrophage lineage and in CD4+ T lymphocytes.J Leukoc Biol. 2010 Apr;87(4):575-88. doi: 10.1189/jlb.0409264. Epub 2009 Oct 2. J Leukoc Biol. 2010. PMID: 19801499 Review.
Cited by
-
Bryostatin modulates latent HIV-1 infection via PKC and AMPK signaling but inhibits acute infection in a receptor independent manner.PLoS One. 2010 Jun 16;5(6):e11160. doi: 10.1371/journal.pone.0011160. PLoS One. 2010. PMID: 20585398 Free PMC article.
-
Treatment of chronically FIV-infected cats with suberoylanilide hydroxamic acid.Antiviral Res. 2014 Aug;108:74-8. doi: 10.1016/j.antiviral.2014.05.014. Epub 2014 Jun 2. Antiviral Res. 2014. PMID: 24954265 Free PMC article.
-
Achieving a cure for HIV infection: do we have reasons to be optimistic?J Antimicrob Chemother. 2012 May;67(5):1063-74. doi: 10.1093/jac/dkr599. Epub 2012 Feb 1. J Antimicrob Chemother. 2012. PMID: 22294645 Free PMC article. Review.
-
Cellular reservoirs of HIV-1 and their role in viral persistence.Curr HIV Res. 2008 Sep;6(5):388-400. doi: 10.2174/157016208785861195. Curr HIV Res. 2008. PMID: 18855649 Free PMC article. Review.
-
Immunotoxin complementation of HAART to deplete persisting HIV-infected cell reservoirs.PLoS Pathog. 2010 Jun 10;6(6):e1000803. doi: 10.1371/journal.ppat.1000803. PLoS Pathog. 2010. PMID: 20548940 Free PMC article. No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical